Analysis of the GENT2 database, using expression profiles from the U133_Plus_2.0 microarray platform (GPL570), showed significant upregulation of CD70 in breast, colon, head and neck, kidney, lung, oral, ovary, spleen, thyroid, and uterine cancers compared to adjacent normal tissues. Here, CD70 is linked to uterine cancer.